Download PDFPDF

P12.08 Targeting tumor-reduced drug accessibility to counteract organ-specific resistance to anti-CD22 immunotoxins
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address